Are plant extracts a potential therapeutic approach for genital infections?

Current Medicinal Chemistry

Volumn 20, Issue 23, 2013, Pages 2914-2928

  Palmeira de Oliveira, A ^a   Silva, B M ^a   Palmeira de Oliveira, R ^a   Martinez de Oliveira, J ^a,b   Salgueiro, L ^c  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b Hospital Center Cova da Beira   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Antimicrobial activity; Delivery systems; Essential oils; Genital infections; Natural compounds; Plant extracts

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CAMPHOR; CARVACROL; CARVONE; CARYOPHYLLENE; CINEOLE; CINNAMIC ACID; CITRAL; COUMARIC ACID; EPIGALLOCATECHIN; EUGENOL; FLAVONOID; GALLOCATECHIN; IRIDOID; LINALOOL; MENTHOL; MENTHONE; OCIMENE; PHENOL; PLANT EXTRACT; POLYPHENOL; SHIKIMIC ACID; SPATHULENOL; TERPENE; TERPINEN 4 OL; TERPINEOL; THYMOL;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTEMISIA; ARTEMISIA AUCHERI; ARTICHOKE; ARTICLE; CANDIDA; CAPSICUM FRUTESCENS; CINNAMOMUM ZEYLANICUM; CISTUS; CYMBOPOGON CITRATUS; DALBERGIA COCHINCHINENSIS; DATURA METEL; DRUG BINDING; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; GARDNERELLA; GARDNERELLA VAGINALIS; GARLIC; GENITAL TRACT INFECTION; GONOCARYUM SUBSTRATUM; HALOXYLON SALICORNIUM; HUMAN; JATROPHA CURCAS; JUGLANS REGIA; LAVANDULA MULTIFIDA; LAVENDER; LIGUSTRUM CONFUSUM; LYTHRUM SALICARIA; MEDICINAL PLANT; MELALEUCA; MELALEUCA ARMILLARIS; MELALEUCA ERICIFOLIA; MELALEUCA LEUCADENDRON; MENTHA PIPERITA; MYRTLE; NONHUMAN; ONION; ORIGANUM VIRENS; PAPILLOMAVIRUS INFECTION; SOLANUM CHRYSOTRICHUM; SOLANUM TORVUM; TEA; THYMBRA CAPITATA; THYME; THYMUS; THYMUS MASTICHINA; THYMUS PULEGIOIDES; THYMUS ZYGIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS; WART VIRUS; ZATARIA MULTIFLORA;

ANTI-INFECTIVE AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; FEMALE; FUNGI; HUMANS; PLANTS; REPRODUCTIVE TRACT INFECTIONS; VIRUSES;

EID: 84880308796     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990007     Document Type: Article

References (145)

1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod., 2012, 75 (3), 311-335.
2. Hostettmann, K.; Marston, A. Twenty years of research into medicinal plants: Results and perspectives. Phytochem. Rev., 2002, 1 (3), 275-285.
3. Mulzer, J.; Bohlmann, R. The role of natural products in drug discovery (Ernst Schering Research Foundation Workshop 32). 1st ed. Springer Verlag: Berlin, 2000.
4. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70 (3), 461-477.
5. Pauli, A. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev., 2006, 26 (2), 223-268.
6. Cravotto, G.; Boffa, L.; Genzini, L.; Garella, D. Phytotherapeutics: An evaluation of the potential of 1000 plants. J. Clin. Pharm. Ther., 2010, 35 (1), 11-48.
7. Mukherjee, P.K. Quality Control of Herbal Drugs. An approach to evaluation of botanicals. Business Horizons: New Delhi, 2002.
8. Clark, A.M. Natural products as a resource for new drugs. Pharmaceut. Res., 1996, 13 (8), 1133-1144.
9. Paterson, I.; Anderson, E.A. Chemistry. The renaissance of natural products as drug candidates. Science, 2005, 310 (5747), 451-453.
10. Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 2005, 4 (3), 206-220.
11. Kent, H.L. Epidemiology of vaginitis. Am. J. Obstet. Gynecol., 1991, 165 (4 Pt 2), 1168-1176.
12. Nyirjesy, P.; Robinson, J.; Mathew, L.; Lev-Sagie, A.; Reyes, I.; Culhane, J.F. Alternative therapies in women with chronic vaginitis. Obstet. Gynecol., 2011, 117 (4), 856-861.
13. Schmid, G.P. The epidemiology of bacterial vaginosis. Int. J. Gynaecol. Obstet., 1999, 67 Suppl 1, S17-S20.
14. Centers for Disease Control and Prevention, C.D.C. Sexually Transmited Diseases Treatment Guidelines, Vol.55, No. RR-11 www.cdc.gov (15-06-2009)
15. Schwebke, J.R.; Desmond, R.A.; Oh, M.K. Predictors of bacterial vaginosis in adolescent women who douche. Sex. Transm. Dis., 2004, 31 (7), 433-436.
16. Barcelos, M.R.; Vargas, P.R.; Baroni, C.; Miranda, A.E. [Genital infections in women attending a Primary Unit of Health: Prevalence and risk behaviors]. Rev. Bras. Ginecol. Obstet., 2008, 30 (7), 349-354.
17. Gardner, H.L.; Dukes, C.D. Haemophilus vaginalis vaginitis: A newly defined specific infection previously classified non-specific vaginitis. Am. J. Obstet. Gynecol., 1955, 69 (5), 962-976.
18. Sobel, J.D. What's new in bacterial vaginosis and trichomoniasis? Infect. Dis. Clin. North Am., 2005, 19 (2), 387-406.
19. Aroutcheva, A.A.; Simoes, J.A.; Behbakht, K.; Faro, S. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin. Infect. Dis., 2001, 33 (7), 1022-1027.
20. Amsel, R.; Totten, P.A.; Spiegel, C.A.; Chen, K.C.; Eschenbach, D.; Holmes, K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med., 1983, 74 (1), 14-22.
21. Beigi, R.H.; Austin, M.N.; Meyn, L.A.; Krohn, M.A.; Hillier, S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am. J. Obstet. Gynecol., 2004, 191 (4), 1124-1129.
22. Austin, M.N.; Beigi, R.H.; Meyn, L.A.; Hillier, S.L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J. Clin. Microbiol., 2005, 43 (9), 4492-4497.
23. Hurley, R.; De Louvois, J. Candida vaginitis. Postgrad. Med. J., 1979, 55 (647), 645-647.
24. Foxman, B.; Marsh, J.V.; Gillespie, B.; Sobel, J.D. Frequency and response to vaginal symptoms among white and African American women: Results of a random digit dialing survey. J. Womens Health, 1998, 7 (9), 1167-1174.
25. Sobel, J.D. Vulvovaginal candidosis. Lancet, 2007, 369 (9577), 1961-1971.
26. Mardh, P.A.; Rodrigues, A.G.; Genc, M.; Novikova, N.; Martinezde-Oliveira, J.; Guaschino, S. Facts and myths on recurrent vulvovaginal candidosis-A review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int. J. STD. AIDS., 2002, 13 (8), 522-539.
27. Sobel, J.D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol., 1985, 152 (7 Pt 2), 924-935.
28. Watson, M.C.; Grimshaw, J.M.; Bond, C.M.; Mollison, J.; Ludbrook, A. Oral versus intra-vaginal imidazole and triazole antifungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): A systematic review. BJOG, 2002, 109 (1), 85-95.
29. Patel, S.R.; Wiese, W.; Patel, S.C.; Ohl, C.; Byrd, J.C.; Estrada, C.A. Systematic review of diagnostic tests for vaginal trichomoniasis. Infect. Dis. Obstet. Gynecol., 2000, 8 (5-6), 248-257.
30. Schwebke, J.R.; Burgess, D. Trichomoniasis. Clin. Microbiol. Rev., 2004, 17 (4), 794-803, table of contents.
31. Upcroft, P.; Upcroft, J.A. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin. Microbiol. Rev., 2001, 14 (1), 150-164.
32. Upcroft, J.A.; Campbell, R.W.; Benakli, K.; Upcroft, P.; Vanelle, P. Efficacy of new 5-nitroimidazoles against metronidazolesusceptible and-resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob. Agents Chemother., 1999, 43 (1), 73-76.
33. Calzada, F.; Yepez-Mulia, L.; Tapia-Contreras, A. Effect of Mexican medicinal plant used to treat trichomoniasis on Trichomonas vaginalis trophozoites. J. Ethnopharmacol., 2007, 113 (2), 248-251.
34. Muelas-Serrano, S.; Nogal, J.J.; Martinez-Diaz, R.A.; Escario, J.A.; Martinez-Fernandez, A.R.; Gomez-Barrio, A. In vitro screening of american plant extracts on Trypanosoma cruzi and trichomonas vaginalis. J. Ethnopharmacol., 2000, 71 (1-2), 101-107.
35. Baseman, J.G.; Koutsky, L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol., 2005, 32 Suppl 1, S16-S24.
36. Arbyn, M.; Castellsague, X.; de Sanjose, S.; Bruni, L.; Saraiya, M.; Bray, F.; Ferlay, J. Worldwide burden of cervical cancer in 2008. Ann. Oncol., 2011, 22 (12), 2675-2686.
37. Stanley, M.A. Genital human papillomavirus infections: Current and prospective therapies. J. Gen. Virol., 2012, 93 (Pt 4), 681-691.
38. Scheinfeld, N.; Lehman, D.S. An evidence-based review of medical and surgical treatments of genital warts. Dermatol. Online J., 2006, 12 (3), 5.
39. Snoeck, R.; Bossens, M.; Parent, D.; Delaere, B.; Degreef, H.; Van Ranst, M.; Noel, J.C.; Wulfsohn, M.S.; Rooney, J.F.; Jaffe, H.S.; De Clercq, E. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin. Infect. Dis., 2001, 33 (5), 597-602.
40. Tatti, S.; Stockfleth, E.; Beutner, K.R.; Tawfik, H.; Elsasser, U.; Weyrauch, P.; Mescheder, A. Polyphenon E: A new treatment for external anogenital warts. Br. J. Dermatol., 2010, 162 (1), 176-184.
41. Koroch, A.; Juliani, R.; Zygadlo, J. In Flavour Frag. J. RG, B., Ed.; Springer Press: Berlin, 2007, 87-115.
42. Van Kessel, K.; Assefi, N.; Marrazzo, J.; Eckert, L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review. Obstet. Gynecol. Surv., 2003, 58 (5), 351-358.
43. Vermani, K.; Garg, S. Herbal medicines for sexually transmitted diseases and AIDS. J. Ethnopharmacol., 2002, 80 (1), 49-66.
44. Kanta, V.; Unnati, S.; Ritu, M. A Review on: AIDS and Herbal Remedies. IJRAP, 2011, 2 (6), 1709-1713.
45. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils-A review. Food Chem. Toxicol., 2008, 46 (2), 446-475.
46. Fresno, A. Farmacognosia Generale. Editorial Sintese SA: Madrid, 1999.
47. Samuelsson, G. Drugs of Natural Origin: A Textbook of Pharmacognosy. 4th ed. Swedish Pharmaceutical Press: Stockholm, 1999.
48. Bouwmeester, H.J. Engineering the essence of plants. Nat. Biotechnol., 2006, 24 (11), 1359-1361.
49. Carson, C.F.; Hammer, K.A.; Riley, T.V. Melaleuca alternifolia (Tea Tree) oil: A review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev., 2006, 19 (1), 50-62.
50. Farag, R.S.; Shalaby, A.S.; El-Baroty, G.A.; Ibrahim, N.A.; Ali, M.A.; Hassan, E.M. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother. Res., 2004, 18 (1), 30-35.
51. Oliva, B.; Piccirilli, E.; Ceddia, T.; Pontieri, E.; Aureli, P.; Ferrini, A.M. Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett. Appl. Microbiol., 2003, 37 (2), 185-187.
52. Hammer, K.A.; Carson, C.F.; Riley, T.V. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J. Antimicrob. Chemother., 1998, 42 (5), 591-595.
53. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J. Antimicrob. Chemother., 2004, 53 (6), 1081-1085.
54. Carson, C.F.; Riley, T.V. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J. Appl. Bacteriol., 1995, 78 (3), 264-269.
55. Cox, S.D.; Mann, C.M.; Markham, J.L.; Bell, H.C.; Gustafson, J.E.; Warmington, J.R.; Wyllie, S.G. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol., 2000, 88 (1), 170-175.
56. Hammer, K.A.; Carson, C.F.; Riley, T.V. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med. Mycol., 2000, 38, 355-362.
57. International Organization for Standardisation. In ISO 4730:2004: Geneve, Switzerland, 2004.
58. Carson, C.F.; Riley, T.V. Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact. Dermatitis, 2001, 45 (2), 65-67.
59. Hammer, K.A.; Carson, C.F.; Riley, T.V. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob. Agents Chemother., 1999, 43 (1), 196.
60. Viollon, C.; Mandin, D.; Chaumont, J. Activites antagonistes, in vitro, of some essential oils and natural volatile compounds vis a vis the growth of Trichomonas vaginalis. Fitoterapia, 1996, 67, 279-281.
61. Pena, E.F. Melaleuca alternifolia oil. Its use for trichomonal vaginitis and other vaginal infections. Obstet. Gynecol., 1962, 19, 793-795.
62. Azadbakht, M.; Ziai, H.; Shaaban Khani, B. Effect of essential oils of Artemisia Aucheri Boiss. Zataria multiflora Boiss and Mirtus communis L. on Trichomonas vaginalis. J. Med. Plants Res., 2003, 2 (8), 35-40.
63. Bayat, M.; Kousha, A.; Azizi Saragi, A.; Seyed Reza Rohani, R.; Nissiani, M. Study Effects of Some Kinds of Standard Essences over Two Microorganisms (Candida albicans and Gardnerella vaginalis) Related to Leucorrhoea Disease as in vitro. World Applied Sciences Journal, 2008, 5 (4), 418-421.
64. Cosentino, S.; Tuberoso, C.I.; Pisano, B.; Satta, M.; Mascia, V.; Arzedi, E.; Palmas, F. In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett. Appl. Microbiol., 1999, 29 (2), 130-135.
65. Giordani, R.; Regli, P.; Kaloustian, J.; Mikail, C.; Abou, L.; Portugal, H. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother. Res., 2004, 18 (12), 990-995.
66. Pinto, E.; Pina-Vaz, C.; Salgueiro, L.; Goncalves, M.J.; Costa-de-Oliveira, S.; Cavaleiro, C.; Palmeira, A.; Rodrigues, A.; Martinezde-Oliveira, J. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol., 2006, 55, (Pt 10), 1367-1373.
67. Pina-Vaz, C.; Goncalves Rodrigues, A.; Pinto, E.; Costa-de-Oliveira, S.; Tavares, C.; Salgueiro, L.; Cavaleiro, C.; Goncalves, M.J.; Martinez-de- Oliveira, J. Antifungal activity of Thymus oils and their major compounds. J. Eur. Acad. Dermatol. Venereol., 2004, 18 (1), 73-78.
68. Salgueiro, L.; Pinto, E.; Gonçalves, M.J.; Costa, I.; Palmeira, A.; Cavaleiro, C.; Pina-Vaz, C.; Rodrigues, A.G.; Martinez-de-Oliveira, A. Antifungal activity of the essential oil of Thymus capitellatus against Candida, Aspergillus and dermatophyte strains. Flavour Fragr. J., 2006, 21, 749-753.
69. Faleiro, M.L.; Miguel, M.G.; Ladeiro, F.; Venancio, F.; Tavares, R.; Brito, J.C.; Figueiredo, A.C.; Barroso, J.G.; Pedro, L.G. Antimicrobial activity of essential oils isolated from Portuguese endemic species of Thymus. Lett. Appl. Microbiol., 2003, 36 (1), 35-40.
70. Braga, P.C.; Culici, M.; Alfieri, M.; Dal Sasso, M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int. J. Antimicrob. Agents, 2008, 31 (5), 472-477.
71. Braga, P.C.; Dal Sasso, M.; Culici, M.; Spallino, A. Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: In vitro study. Arzneimittelforschung, 2010, 60 (11), 675-681.
72. Tampieri, M.P.; Galuppi, R.; Macchioni, F.; Carelle, M.S.; Falcioni, L.; Cioni, P.L.; Morelli, I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia, 2005, 159 (3), 339-345.
73. Salgueiro, L.R.; Pinto, E.; Goncalves, M.J.; Pina-Vaz, C.; Cavaleiro, C.; Rodrigues, A.G.; Palmeira, A.; Tavares, C.; Costade-Oliveira, S.; Martinez-de-Oliveira, J. Chemical composition and antifungal activity of the essential oil of Thymbra capitata. Planta Medica, 2004, 70 (6), 572-575.
74. Salgueiro, L.R.; Cavaleiro, C.; Pinto, E.; Pina-Vaz, C.; Rodrigues, A.G.; Palmeira, A.; Tavares, C.; Costa-de-Oliveira, S.; Goncalves, M.J.; Martinez-de-Oliveira, J. Chemical composition and antifungal activity of the essential oil of Origanum virens on Candida species. Planta Med., 2003, 69 (9), 871-874.
75. Palmeira-de-Oliveira, A.; Gaspar, C.; Palmeira-de-Oliveira, R.; Silva-Dias, A.; Salgueiro, L.; Cavaleiro, C.; Pina-Vaz, C.; Martinez-de- Oliveira, J.; Queiroz, J.A.; Rodrigues, A.G. The anti-Candida activity of Thymbra capitata essential oil: Effect upon preformed biofilm. J. Ethnopharmacol., 2012, 140 (2), 379-383.
76. Sahin, F. Biological activities of the essential oils and methanol extract of Origanum vulgare spp vulgare in the Eastern Anatolia region of Turkey. Food Control, 2004, 15, 549-557.
77. Zuzarte, M.; Vale-Silva, L.; Gonçalves, M.; Cavaleiro, C.; Vaz, S.; Canhoto, J.; Pinto, E.; Salgueiro, L. Antifungal activity of phenolic-rich Lavandula multifida L. essential oil. Eur. J. Clin. Microbiol., 2012, 31 (7), 1359-1366.
78. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol., 1999, 86 (6), 985-990.
79. Duarte, M.C.; Figueira, G.M.; Sartoratto, A.; Rehder, V.L.; Delarmelina, C. Anti-Candida activity of Brazilian medicinal plants. J. Ethnopharmacol., 2005, 97 (2), 305-311.
80. Hili, P.; Evans, C.S.; Veness, R.G. Antimicrobial action of essential oils: The effect of dimethylsulphoxide on the activity of cinnamon oil. Lett. Appl. Microbiol., 1997, 24 (4), 269-275.
81. Agarwa, V.; Lal, P.; Pruthi, V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia, 2008, 165, 13-19.
82. da Silva C de, B.; Guterres, S.S.; Weisheimer, V.; Schapoval, E.E. Antifungal activity of the lemongrass oil and citral against Candida spp. Braz. J. Infect. Dis., 2008, 12 (1), 63-66.
83. Devkatte, A.N.; Zore, G.B.; Karuppayil, S.M. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeasts Res., 2005, 5, 867-873.
84. Schwiertz, A.; Duttke, C.; Hild, J.; Müller, H.J. In vitro activity of essential oils on microorganisms isolated from vaginal infections. International Journal of Aromatherapy, 2006, 16 (3-4), 169-174.
85. Bozin, B.; Mimica-Dukic, N.; Samojlik, I.; Jovin, E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food. Chem., 2007, 55 (19), 7879-7885.
86. Pinto, E.; Salgueiro, L.R.; Cavaleiro, C.; Palmeira, A.; Gonçalves, M.J. In vitro susceptibility of some species of yeasts and filamentous fungi to essential oils of Salvia officinalis. Ind. Crop. Prod., 2007, 26, 135-141.
87. Bruneton, J. In Pharmacognosie, phytochimie, plantes médicinales. Lavoisier, T.e.d., Ed.: Paris, 1999.
88. Tavares, C.B.; Pina-Vaz, C.; Rodrigues, A.G.; Costa-de-Oliveira, S.; Pinto, E.; Salgueiro, L.; Cavaleiro, C.; Gonçalves, M.J.; Palmeira, A.; Martinez-de-Oliveira, J. The fungicidal activity of eugenol on Candida spp results from a primary lesion of the cell membrane. Clin. Microbiol. Infect., 2003, 9 (1), 89.
89. Kurita, N.; Miyaji, M.; Kurane, R.; Takahara, Y. Antifungal Activity of Components of Essential Oils. Agric. Biol. Chem., 1981, 45 (4), 945-952.
90. Ahmad, N.; Alam, M.K.; Shehbaz, A.; Khan, A.; Mannan, A.; Hakim, S.R.; Bisht, D.; Owais, M. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J. Drug Target., 2005, 13 (10), 555-561.
91. Divya, C.S.; Pillai, M.R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol. Carcinog., 2006, 45 (5), 320-332.
92. Almajano, M.P.; Carbó, R.; Angel López Jiménez, J.; Gordon, M.H. Antioxidant and antimicrobial activities of tea infusions. Food Chem., 2008, 108, 55-63.
93. Cheng, S.J.; Wang, D.C.; Hara, Y. Composition for treating Condyloma acuminata 1998.
94. Hirasawa, M.; Takada, K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J. Antimicrob. Chemother., 2004, 53 (2), 225-229.
95. Meltzer, S.M.; Monk, B.J.; Tewari, K.S. Green tea catechins for treatment of external genital warts. Am. J. Obstet. Gynecol., 2009, 200 (3), 233 e231-237.
96. Navarro-Martinez, M.D.; Garcia-Canovas, F.; Rodriguez-Lopez, J.N. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. J. Antimicrob. Chemother., 2006, 57 (6), 1083-1092.
97. Turchetti, B.; Pinelli, P.; Buzzini, P.; Romani, A.; Heimler, D.; Franconi, F.; Martini, A. In vitro antimycotic activity of some plant extracts towards yeast and yeast-like strains. Phytother. Res., 2005, 19 (1), 44-49.
98. Zou, C.; Liu, H.; Feugang, J.M.; Hao, Z.; Chow, H.H.; Garcia, F. Green tea compound in chemoprevention of cervical cancer. Int. J. Gynecol. Cancer, 2010, 20 (4), 617-624.
99. Cheng, S.J.B., CN) ; Wang, D.C.B., CN) ; Hara, Y.F., JP) ; Lee, I.P.S., KR) ; Ahn, W.S.S., KR) Methods for treating hyperplasia. 2001.
100. Ahn, W.S.; Huh, S.W.; Bae, S.M.; Lee, I.P.; Lee, J.M.; Namkoong, S.E.; Kim, C.K.; Sin, J.I. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell. Biol., 2003, 22 (3), 217-224.
101. Ahn, W.S.; Yoo, J.; Huh, S.W.; Kim, C.K.; Lee, J.M.; Namkoong, S.E.; Bae, S.M.; Lee, I.P. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev., 2003, 12 (5), 383-390.
102. Di Domenico, F.; Foppoli, C.; Coccia, R.; Perluigi, M. Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols. Biochim. Biophys. Acta, 2012, 1822 (5), 737-747.
103. Maher, D.M.; Bell, M.C.; O'Donnell, E.A.; Gupta, B.K.; Jaggi, M.; Chauhan, S.C. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Mol. Carcinog., 2011, 50 (1), 47-57.
104. Rauha, J.P.; Remes, S.; Heinonen, M.; Hopia, A.; Kahkonen, M.; Kujala, T.; Pihlaja, K.; Vuorela, H.; Vuorela, P. Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. Int. J. Food Microbiol., 2000, 56 (1), 3-12.
105. Pereira, J.A.; Oliveira, I.; Sousa, A.; Ferreira, I.C.; Bento, A.; Estevinho, L. Bioactive properties and chemical composition of six walnut (Juglans regia L.) cultivars. Food Chem. Toxicol., 2008, 46 (6), 2103-2111.
106. Zhu, X.; Zhang, H.; Lo, R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J. Agric. Food Chem., 2004, 52 (24), 7272-7278.
107. Ferreira, S.; Santos, J.; Duarte, A.; Duarte, A.P.; Queiroz, J.A.; Domingues, F.C. Screening of antimicrobial activity of Cistus ladanifer and Arbutus unedo extracts. Nat. Prod. Res., 2012, 26 (16), 1558-1560.
108. Arthan, D.; Sithiprom, S.; Thima, K.; Limmatvatirat, C.; Chavalitshewinkoon-Petmitr, P.; Svasti, J. Inhibitory effects of Thai plants beta-glycosides on Trichomonas vaginalis. Parasitol. Res., 2008, 103 (2), 443-448.
109. Evans, W. Pharmacognosy. 16th ed. Elsevier: London, 2009.
110. Gonzalez, M.; Zamilpa, A.; Marquina, S.; Navarro, V.; Alvarez, L. Antimycotic spirostanol saponins from Solanum hispidum leaves and their structure-activity relationships. J. Nat. Prod., 2004, 67 (6), 938-941.
111. Renault, S.; De Lucca, A.J.; Boue, S.; Bland, J.M.; Vigo, C.B.; Selitrennikoff, C.P. CAY-1, a novel antifungal compound from cayenne pepper. Med. Mycol., 2003, 41 (1), 75-81.
112. Zamilpa, A.; Tortoriello, J.; Navarro, V.; Delgado, G.; Alvarez, L. Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity. J. Nat. Prod., 2002, 65 (12), 1815-1819.
113. Osbourn, A. Saponins and plant defence-A soap story. Trends Plant Sci., 1996, 1 (1), 4-9.
114. Roddick, J.G.; Weissenberg, M.; Leonard, A.L. Membrane disruption and enzyme inhibition by naturally-occurring and modified chacotriose-containing Solanum steroidal glycoalkaloids. Phytochemistry, 2001, 56 (6), 603-610.
115. Chavez, B.; Martinez-Palomo, A. Giardia lamblia: Freeze-fracture ultrastructure of the ventral disc plasma membrane. J. Eukaryot. Microbiol., 1995, 42 (2), 136-141.
116. Roberts, C.W.; McLeod, R.; Rice, D.W.; Ginger, M.; Chance, M.L.; Goad, L.J. Fatty acid and sterol metabolism: Potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol. Biochem. Parasitol., 2003, 126 (2), 129-142.
117. Emam, A.M.; Moussa, A.M.; Faure, R.; Favel, A.; Delmas, F.; Elias, R.; Balansard, G. Isolation and biological study of a triterpenoid saponin, mimengoside A, from the leaves of Buddleja madagascariensis. Planta Med., 1996, 62 (1), 92-93.
118. Pereira, A.P.; Ferreira, I.C.; Marcelino, F.; Valentao, P.; Andrade, P.B.; Seabra, R.; Estevinho, L.; Bento, A.; Pereira, J.A. Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrancosa) leaves. Molecules, 2007, 12 (5), 1153-1162.
119. Klausmeyer, P.; Chmurny, G.N.; McCloud, T.G.; Tucker, K.D.; Shoemaker, R.H. A novel antimicrobial indolizinium alkaloid from Aniba panurensis. J. Nat. Prod., 2004, 67 (10), 1732-1735.
120. Dabur, R.; Chhillar, A.K.; Yadav, V.; Kamal, P.K.; Gupta, J.; Sharma, G.L. In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl) -1-methylethyl pentanoate, a dihydropyrrole derivative. J. Med. Microbiol., 2005, 54 (Pt 6), 549-552.
121. Ferheen, S.; Ahmed, E.; Afza, N.; Malik, A.; Shah, M.R.; Nawaz, S.A.; Choudhary, M.I. Haloxylines A and B, antifungal and cholinesterase inhibiting piperidine alkaloids from Haloxylon salicornicum. Chem. Pharm. Bull. (Tokyo), 2005, 53 (5), 570-572.
122. Slobodnikova, L.; Kost'alova, D.; Labudova, D.; Kotulova, D.; Kettmann, V. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother. Res., 2004, 18 (8), 674-676.
123. Iwasa, K.; Moriyasu, M.; Yamori, T.; Turuo, T.; Lee, D.U.; Wiegrebe, W. In vitro cytotoxicity of the protoberberine-type alkaloids. J. Nat. Prod., 2001, 64 (7), 896-898.
124. Park, K.S.; Kang, K.C.; Kim, J.H.; Adams, D.J.; Johng, T.N.; Paik, Y.K. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. J. Antimicrob. Chemother., 1999, 43 (5), 667-674.
125. Aiyelaaagbe, O.O.; Adeniyi, B.A.; Fatnsin, O.F.; Arimah, B.D. In vitro antimicrobial activity and phytochemical analysis of Jatropha curcas roots. Int. J. Pharmacol., 2007, 3 (1), 1006-1110.
126. Shams-Ghahfarokhi, M.; Shokoohamiri, M.-R.; Amirrajab, N.; Moghadasi, B.; Ghajari, A.; Zeini, F.; Sadeghi, G.; Razzaghi-Abyaneh, M. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes. Fitoterapia, 2006, 77 (4), 321-323.
127. Bahadoran, P.; Rokni, F.K.; Fahami, F. Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran. J. Nurs. Midwifery Res., 2010, 15, (Suppl 1), 343-349.
128. Ahmad, N.; Alam, M.K.; Shehbaz, A.; Khan, A.; Mannan, A.; Hakim, S.R.; Bisht, D.; Owais, M. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J. Drug Target, 2005, 13 (10), 555-561.
129. Manou, I.; Bouillard, L.; Devleeschouwer, M.J.; Barel, A.O. Evaluation of the preservative properties of Thymus vulgaris essential oil in topically applied formulations under a challenge test. J. Appl. Microbiol., 1998, 84 (3), 368-376.
130. Hammer, K.A.; Carson, C.F.; Riley, T.V. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J. Antimicrob. Chemother., 1998, 42 (5), 591-595.
131. das Neves, J.; Pinto, E.; Amaral, M.H.; Bahia, M.F. Antifungal activity of a gel containing Thymus vulgaris essential oil against Candida species commonly involved in vulvovaginal candidosis. Pharm. Biol., 2009, 47 (2), 151-153.
132. Singh, K.K.; Parmar, S.; Tatke, P.A. Contraceptive efficacy and safety of HerbOshield vaginal gel in rats. Contraception, 2012, 85 (1), 122-127.
133. das Neves, J.; Amaral, M.H.; Bahia, M.F. In Pharmaceutical Manufacturing Handbook: Production and Processes. SC, G., Ed.; Wiley: Hoboken, 2008, 809-878.
134. Lai, F.; Loy, G.; Manconi, M.; Manca, M.L.; Fadda, A.M. Artemisia arborescens L essential oil loaded beads: Preparation and characterization. AAPS PharmSciTech, 2007, 8 (3), E67.
135. Hammer, K.A.; Carson, C.F.; Riley, T.V.; Nielsen, J.B. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem. Toxicol., 2006, 44 (5), 616-625.
136. Reichling, J.; Landvatter, U.; Wagner, H.; Kostka, K.H.; Schaefer, U.F. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations. Eur. J. Pharm. Biopharm., 2006, 64 (2), 222-228.
137. Elias, C.; Coggins, C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J. Womens Health Gend. Based Med., 2001, 10 (2), 163-173.
138. Bagga, R.; Raghuvanshi, P.; Gopalan, S.; Das, S.K.; Baweja, R.; Suri, S.; Malhotra, D.; Khare, S.; Talwar, G.P. A polyherbal vaginal pessary with spermicidal and antimicrobial action: Evaluation of its safety. Trans. R. Soc. Trop. Med. Hyg., 2006, 100 (12), 1164-1167.
139. Valenta, C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev., 2005, 57 (11), 1692-1712.
140. Chopra, S.; Motwani, S.K.; Iqbal, Z.; Talegaonkar, S.; Ahmad, F.J.; Khar, R.K. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur. J. Pharm. Biopharm., 2007, 67 (1), 120-131.
141. Lima, C.S.; de Medeiros, B.J.; Favacho, H.A.; dos Santos, K.C.; de Oliveira, B.R.; Taglialegna, J.C.; da Costa, E.V.; de Campos, K.J.; Carvalho, J.C. Pre-clinical validation of a vaginal cream containing copaiba oil (reproductive toxicology study). Phytomedicine, 2011, 18 (12), 1013-1023.
142. Simbar, M.; Azarbad, Z.; Mojab, F.; Majd, H.A. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis. Phytomedicine, 2008, 15 (12), 1025-1031.
143. Joshi, S.N.; Katti, U.; Godbole, S.; Bharucha, ; Kulkarni, S.; Risbud, A.; Mehendale, S. Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India. Trans. R. Soc. Trop. Med. Hyg., 2005, 99 (10), 769-774.
144. Salhan, S.; Tripathi, V.; Sehgal, R.; Kumar, G.; Talwar, G.P.; Chatterjee, A. A phase II randomized controlled trial to evaluate the safety and efficacy of Praneem polyherbal vaginal tablets compared with betadine vaginal pessary in women with symptoms of abnormal vaginal discharge. Asia Pac. J. Public Health, 2009, 21 (4), 461-468.
145. Sharma, R.S.; Mathur, A.K.; Chandhiok, N.; Datey, S.; Saxena, N.C.; Gopalan, S.; Sharma, S.; Mittal, S.; Sehgal, R.; Sumandal, B.K.; Chanda, A.; Salvi, V.; Mutalik, N.; Coyaji, K.J.; Gibsson, A.; Hazari, K.; Kalgutkar, S.; Talwar, G.P. Phase II clinical trial with Praneem polyherbal tablets for assessment of their efficacy in symptomatic women with abnormal vaginal discharge (an ICMR task force study). Trans. R. Soc. Trop. Med. Hyg., 2009, 103 (2), 167-172.